Telbivudine

本公司产品仅用于科研实验，不得用于人体或动物的临床与诊断

Telbivudine 是一种乙型肝炎病毒核苷类似物逆转录酶抑制剂。

Telbivudine is a Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor. The mechanism of action of telbivudine is as a Nucleoside Reverse Transcriptase Inhibitor. The chemical classification of telbivudine is Nucleoside Analog.(In Vitro):Telbivudine reverses B19V-induced dysregulation of BIRC3, thus, intervening in the apoptosis pathway and protecting susceptible cells from cell death.

Telbivudine reverses B19V-induced dysregulation of BIRC3, thus, intervening in the apoptosis pathway and protecting susceptible cells from cell death.

——

LDT 600 | LD-T600 | LDT600 | Telbivudine | Tyzeka | Epavudine

Microbiology/Virology

Other Targets

Protein P| Reverse Transcriptase| Reverse Transcriptase

Infection

——

3424-98-4

242.23

C10H14N2O5

>98% (HPLC)

Ethanol: 2 mg/mL warmed (8.25 mM); Water: 48 mg/mL warmed (198.15 mM); DMSO: 48 mg/mL warmed (198.15 mM)

O=C1NC(C(C)=CN1[C@@H]2C[C@H]([C@H](CO)O2)O)=O

1-((2S,4R,5S)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione

(-20℃)

With Ice Pack

≥ 2 years